Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole with or without Rikkunshi-to in functional dyspepsia
jRCT1061220076Recruiting
- Start
- Dec 2022
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in functional dyspepsia (FD) comparing Esomeprazole monotherapy with Esomeprazole + Rikkunshi-to (2 arms). Primary endpoint: Symptom improvement at 2 weeks. Started Dec 2022; status: recruiting.
02
Drugs
esomeprazolerikkunshito
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on jRCT1061220076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061220076.